CymaBay Therapeutics, Inc.

Sümbol: CBAY

NASDAQ

32.48

USD

Turuhind täna

-32.9591
P/E suhe
0.0000
PEG suhe
3.73B
MRK Cap
0.00%
DIV tootlus

CymaBay Therapeutics, Inc. (CBAY) Finantsaruanded

Q: Mis on CymaBay Therapeutics, Inc. (CBAY) koguvara?

CymaBay Therapeutics, Inc. (CBAY) koguvara on .

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete CymaBay Therapeutics, Inc. (CBAY) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 3.677 M, mis on -0.167 % gowth. Kogu perioodi keskmine brutokasum on 3.384 M, mis on 3.491 %. Keskmine brutokasumi suhtarv on 0.248 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.114 %, mis on võrdne -0.408 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes CymaBay Therapeutics, Inc. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus 2.064. Käibevara valdkonnas on CBAY aruandlusvaluutas 403.802. Märkimisväärne osa neist varadest, täpsemalt 394.255, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 1.910%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 22.36, kui neid on, aruandlusvaluutas. See näitab erinevust 0.000% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 99.172 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on 0.259%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 292.256 aruandlusvaluutas. Selle aspekti aastane muutus on 7.084%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 0, varude hind on 0 ja firmaväärtus 0, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 0.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012
balance-sheet.row.cash-and-short-term-investments	1283.24	394.3	135.5	186.5	146.3	190.9	178.7	97.2	17	41.5	34.8	31.2	7.7
balance-sheet.row.short-term-investments	708.35	187.7	115.2	60.7	118.1	166.1	129.7	74.2	6.5	33.8	23.2	6.8	0
balance-sheet.row.net-receivables	0	0	0	0	0.3	0.7	0	5	0	0.2	0.3	0.2	0.1
balance-sheet.row.inventory	0	0	0	0	0	0	0	1.2	0	0	2	0.4	0
balance-sheet.row.other-current-assets	35.01	9.5	2.6	4.6	5	11.3	0.3	0.1	0.2	1.1	0.1	0.5	0.1
balance-sheet.row.total-current-assets	1318.25	403.8	138.1	191.1	151.6	202.9	181.6	103.5	18.5	42.8	37.2	32.2	8
balance-sheet.row.property-plant-equipment-net	7.83	5.7	0.9	1.4	2	2.6	2.9	0.1	0.1	0.1	0.1	0	0.1
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	22.36	22.4	0	8.1	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	9.26	2.8	2.9	1.7	0.2	0.2	2.3	0.6	0.8	0.2	0.2	0.3	0
balance-sheet.row.total-non-current-assets	39.45	30.9	3.8	11.2	2.2	2.8	5.2	0.7	0.8	0.3	0.2	0.3	0.1
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	1357.7	434.7	141.9	202.3	153.8	205.7	186.7	104.2	19.4	43.1	37.5	32.5	8.1
balance-sheet.row.account-payables	12.78	3.8	1.1	2.7	0.2	2.5	2	1.3	0.9	1	2.1	0.7	0.7
balance-sheet.row.short-term-debt	11.12	10	0.7	0.6	0.5	0.4	0	3.1	2.7	0.5	1.4	0	13.7
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	397.14	99.2	90.3	51	1.3	1.7	0	3	6.1	8.8	3.2	4.4	0
Deferred Revenue Non Current	3.3	1.1	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-203.34	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	58.31	21.3	13.7	15.1	9.1	14.7	12.4	6.1	1.1	1.2	13.6	6.9	3.6
balance-sheet.row.total-non-current-liabilities	405.76	105.6	90.3	51	1.3	1.7	1.9	3	6.1	8.8	3.2	4.4	318.7
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	6.43	5.3	0.7	1.3	1.7	2.1	0	0	0	0	0	0	0
balance-sheet.row.total-liab	526.66	142.4	105.7	69.4	11.1	19.4	16.3	19.3	15.4	15	23.6	13.9	336.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	32.5	0
balance-sheet.row.common-stock	0.06	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	-3718.63	-978.2	-872.9	-766.9	-676.9	-625.9	-523.1	-450.5	-423	-396.3	-380.8	-348.8	-329.5
balance-sheet.row.accumulated-other-comprehensive-income-loss	-0.11	0.1	-0.3	0	0	0.1	-0.1	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	4549.72	1270.3	909.3	899.8	819.5	812.1	693.5	535.5	426.9	424.4	394.6	334.9	0.9
balance-sheet.row.total-stockholders-equity	831.04	292.3	36.2	132.9	142.7	186.3	170.4	84.9	3.9	28.1	13.8	18.6	-328.6
balance-sheet.row.total-liabilities-and-stockholders-equity	1357.7	434.7	141.9	202.3	153.8	205.7	186.7	104.2	19.4	43.1	37.5	32.5	8.1
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	831.04	292.3	36.2	132.9	142.7	186.3	170.4	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	1357.7	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	730.71	210.1	115.2	68.8	118.1	166.1	129.7	74.2	6.5	33.8	23.2	6.8	0
balance-sheet.row.total-debt	413.58	114.5	90.9	51.6	1.7	2.1	0	6.1	8.8	9.3	4.5	4.4	13.7
balance-sheet.row.net-debt	-161.31	-92	70.6	-74.2	-26.4	-22.7	-49	-17	-1.7	1.6	-7.1	-20	6

Rahavoogude aruanne

CymaBay Therapeutics, Inc. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 0.134 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 345.77, mis tähistab 37.500 erinevust võrreldes eelmise aastaga. Huvitav on see, et osa ettevõtte aktsiatest, täpsemalt 0, ostis ettevõte ise tagasi. Selle tegevuse tulemusena muutus 0.000 võrreldes eelmise aastaga. Vahepeal on ettevõtte võlgnevused praegu 2.73 aruandlusvaluutas. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -86569000.000. See on 0.883 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 0.68, 7.86, 0, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte 0 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui 335.14, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012
cash-flows.row.net-income	-105.37	-105.4	-106	-90	-51	-102.8	-72.5	-27.6	-26.7	-15.5	-31.9	-10.1	-11.3
cash-flows.row.depreciation-and-amortization	0.68	0.7	0.7	0.7	0.6	0.6	0.1	0	0	0	0	0.1	0.1
cash-flows.row.deferred-income-tax	-7.77	-2.7	0	0.6	0	-3.1	1.8	5.6	0.1	-10.6	7.7	-0.1	0
cash-flows.row.stock-based-compensation	15.23	15.2	9.5	10	7.3	10.5	7	4.9	2.5	2.5	1.3	0.9	0.1
cash-flows.row.change-in-working-capital	5.63	5.6	-2.3	6.4	-1.6	-3.9	8.9	-3	0.3	0.1	1.6	0.7	-0.3
cash-flows.row.account-receivables	0	0	0	0	0	0	0	-5	0	0.2	-0.1	0	0
cash-flows.row.inventory	0	0	0	0	0	0	0	1.4	0	0.9	0.3	0.7	0.7
cash-flows.row.account-payables	2.73	2.7	-1.4	2.3	-2.3	0.5	0.7	0.4	-0.1	-1.1	1.4	0	-1
cash-flows.row.other-working-capital	2.9	2.9	-0.9	4	0.7	-4.4	8.2	0.1	0.4	0	0	0	-0.1
cash-flows.row.other-non-cash-items	19.06	14	14	2.9	-0.1	0.9	-0.1	0.4	0.5	0.2	0.2	0.1	0.1
cash-flows.row.net-cash-provided-by-operating-activities	-72.53	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-0.45	-0.4	-0.1	-0.1	0	-0.3	-0.5	0	0	0	-0.1	0	0
cash-flows.row.acquisitions-net	-2.11	-7.9	-0.9	0.6	-0.1	-2.2	-1.9	-0.2	0	0	0	0	0
cash-flows.row.purchases-of-investments	-305.67	-305.7	-175	-78.1	-176.3	-290.9	-276.4	-98.4	-22.9	-42.8	-27.3	-6.9	-2.9
cash-flows.row.sales-maturities-of-investments	219.55	219.6	129.1	126.8	224.3	256.9	222.8	30.9	50.1	31.7	10.5	0	13.9
cash-flows.row.other-investing-activites	2.11	7.9	0.9	-0.6	0.1	2.2	1.9	0.2	0	0	0	0.7	0
cash-flows.row.net-cash-used-for-investing-activites	-86.57	-86.6	-46	48.6	48	-34.3	-54.1	-67.5	27.1	-11.1	-16.9	-6.2	11
cash-flows.row.debt-repayment	0	0	-25	-47.7	0	0	-6.5	-3.1	-1	-4.8	-0.2	0	0
cash-flows.row.common-stock-issued	339.36	345.8	-0.5	70.5	0.1	107.7	135.5	100.4	0	25.4	25.4	26.5	0
cash-flows.row.common-stock-repurchased	0	0	-0.5	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	-25	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	7.46	335.1	75.5	95.7	0.1	0.4	6	2.4	0	9.9	0.1	4.9	0
cash-flows.row.net-cash-used-provided-by-financing-activities	345.77	345.8	24.6	118.5	0.1	108.1	135	99.7	-1	30.5	25.2	31.4	0
cash-flows.row.effect-of-forex-changes-on-cash	26.59	-0.4	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	186.24	186.2	-105.5	97.6	3.3	-24.1	25.9	12.6	2.8	-3.9	-12.8	16.7	-0.3
cash-flows.row.cash-at-end-of-period	574.89	206.5	20.3	125.8	28.2	24.9	49	23.1	10.5	7.7	11.6	24.4	7.7
cash-flows.row.cash-at-beginning-of-period	388.64	20.3	125.8	28.2	24.9	49	23.1	10.5	7.7	11.6	24.4	7.7	8
cash-flows.row.operating-cash-flow	-72.53	-72.5	-84.1	-69.4	-44.7	-97.9	-54.9	-19.6	-23.4	-23.3	-21.1	-8.5	-11.3
cash-flows.row.capital-expenditure	-0.45	-0.4	-0.1	-0.1	0	-0.3	-0.5	0	0	0	-0.1	0	0
cash-flows.row.free-cash-flow	-72.98	-73	-84.2	-69.5	-44.7	-98.2	-55.5	-19.7	-23.4	-23.3	-21.2	-8.5	-11.3

Kasumiaruande rida

CymaBay Therapeutics, Inc. tulud muutusid võrreldes eelmise perioodiga 0.000%. CBAY brutokasum on teatatud 30.39. Ettevõtte tegevuskulud on 132.07, mille muutus võrreldes eelmise aastaga on 41.843%. Kulud amortisatsioonikulud on 0.68, mis on -0.662% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 132.07, mis näitab 41.843% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab -0.092% kasvu võrreldes eelmise aastaga. Tegevustulu on -101.68, mis näitab 0.092% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.114%. Eelmise aasta puhaskasum oli -105.37.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012
income-statement-row.row.total-revenue	31.07	31.1	0	0	0	0	0	10	0	0	0	0	3
income-statement-row.row.cost-of-revenue	0.68	0.7	0.7	0.7	0.6	0.8	0	0	0	0	0	0	0
income-statement-row.row.gross-profit	30.39	30.4	-0.7	-0.7	-0.6	-0.8	0	10	0	0	0	0	3
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	80.74	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	51.95	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	1.76	1.8	0	0	0	5.1	-3.3	-5.8	0.1	11.1	-7.2	0.1	0
income-statement-row.row.operating-expenses	132.7	132.1	93.1	87.6	53.3	103.1	72.5	31.3	25.6	25.9	24	9.4	13.5
income-statement-row.row.cost-and-expenses	132.75	132.8	93.1	87.6	53.3	103.1	72.5	31.3	25.6	25.9	24	9.4	13.5
income-statement-row.row.interest-income	13.49	13.5	2	0.2	1.6	5.3	4	0.6	0.2	0.2	0.1	0	0
income-statement-row.row.interest-expense	9.26	18.9	14.9	2.6	0	0	0.3	1.1	1.3	0.9	0.8	0.8	0.8
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-1.7	-3.7	-12.9	-2.4	1.6	5.3	-3.7	-5.8	0.1	11.1	-7.2	0.1	0
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	1.76	1.8	0	0	0	5.1	-3.3	-5.8	0.1	11.1	-7.2	0.1	0
income-statement-row.row.total-operating-expenses	-1.7	-3.7	-12.9	-2.4	1.6	5.3	-3.7	-5.8	0.1	11.1	-7.2	0.1	0
income-statement-row.row.interest-expense	9.26	18.9	14.9	2.6	0	0	0.3	1.1	1.3	0.9	0.8	0.8	0.8
income-statement-row.row.depreciation-and-amortization	3.18	0.7	2	0.9	-0.8	10.4	0.1	0	0	0	0	0.1	0.1
income-statement-row.row.ebitda-caps	-94.8	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-101.68	-101.7	-93.1	-87.6	-52.6	-108.2	-72.5	-21.3	-25.6	-25.9	-24	-9.4	-10.4
income-statement-row.row.income-before-tax	-105.37	-105.4	-106	-90	-51	-102.8	-72.5	-27.6	-26.7	-15.5	-31.9	-10.1	-11.3
income-statement-row.row.income-tax-expense	11.99	0	12.9	2.6	-2.3	-0.6	0.3	-4.7	1.4	12	-6.5	1	0.8
income-statement-row.row.net-income	-111.68	-105.4	-118.9	-92.6	-48.7	-102.2	-72.5	-27.6	-26.7	-15.5	-31.9	-10.1	-11.3